Vichy Laboratoires is entering a transformative phase as it embraces the growing field of longevity, emphasizing a holistic approach to skin and hair health. The dermocosmetics brand, a subsidiary of L’Oréal, is preparing to present its latest innovations at the European Academy of Dermatology and Venereology symposium in Paris. This is a significant moment for the brand as they unveil two newly launched products: the Vichy Neovadiol Longevity Cream and the Dercos Aminexil Clinical R.E.G.E.N. Booster, which aim not only to enhance beauty but also to promote skin and hair health as a pathway to longevity.
Vincent Chauvière, the global brand president of Vichy Laboratoires, emphasizes that beauty is deeply intertwined with skin health. The company’s direction toward longevity science reflects their commitment to addressing the underlying mechanisms of aging. This innovative approach enables them to tackle biological age rather than just chronological age. In January, Vichy launched the Collagen Specialist 16 line to enhance collagen production in aging skin, a clear pivot towards evolving anti-aging solutions. The new products build upon this foundation, offering targeted support for consumers seeking to preserve youthful skin vitality.
The Neovadiol Longevity Cream specifically targets Baby Boomers, a demographic of increasing significance. This generation, expected to make up 20% of the global population by 2040, is known for its high spending on beauty products. Chauvière notes that the cream enhances the skin’s capacity to regenerate healthy tissue, promising a remarkable increase in youthful skin volume. Such innovations are essential in a market increasingly focused on effective anti-aging solutions.
Meanwhile, the Dercos Aminexil Clinical R.E.G.E.N. Booster expands Vichy’s longevity science into hair care. Chauvière makes it clear that the scalp is an extension of the skin and deserves the same level of care. The serum targets hair at its root, claiming to reduce hair loss while promoting new growth. Initial results have shown a marked increase in hair density, with clinical trials supporting these claims. This shift represents a new era in hair-loss treatment, intertwining longevity with hair health.
Paulina Andrycz, global medical communications director at L’Oréal Dermatological Beauty, highlights the scientific groundwork that informs these products. The research and innovation department has formulated a “longevity wheel” to guide product development. By addressing three key factors—structural, metabolic, and signaling—the R.E.G.E.N. Booster aims for comprehensive hair health. This straightforward formula, supported by extensive clinical research, sets a new benchmark in dermatological standards.
Vichy’s growth trajectory has been impressive, with a reported 10% increase in revenue last year, largely driven by their Dercos line. The brand has seen soaring demand across various markets, including recent expansions into the U.S. Dercos is now recognized as the leading dermocosmetics hair care brand worldwide, endorsed by thousands of dermatologists. With the integration of longevity science into their product offerings, Vichy is positioning itself as a leader in the evolving landscape of dermocosmetics, foreseeing hair care as a pivotal aspect of its future growth strategy.
As Vichy dives deeper into longevity science, it not only enhances its product offerings but also redefines its mission of linking beauty with health. This integrative approach sets the stage for an exciting future in which skincare and hair care are not just about aesthetics but about nurturing the body’s innate potential for self-renewal and longevity.
